A Digitally-Enabled System for Precision Assessment and Intervention of Disability Risk in Older Adults

ConditionDisability
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

1. Identify the primary risk factors for disability in older adults through multi-dimensional risk factor screening. 2. Develop a risk stratification model for disability in older adults by integrating outcome indicators and temporal characteristics, and construct an intelligent early warning model to enable automated assessment and monitoring of disability risk. 3. Establish key digital technologies for early warning and prevention of disability risk in older adults, and develop a whole-process digital intervention platform incorporating a decision support system for disability prevention management. 4. Create a digitally empowered hospital-community-household collaborative system for precise assessment and intervention of disability risk in older adults, achieving data-driven whole-process active disability management. The system will be demonstrated and evaluated in communities with diverse characteristics across urban, county, and rural settings.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Community-dwelling permanent residents aged ≥65 years;

Able to operate a smartphone independently or with assistance from a primary caregiver;

Clear consciousness with basic comprehension and communication abilities;

Voluntarily agree to participate in the study and provide informed consent.

Disqualifiers

Those who are unable to perform basic activities of daily living independently, or who have significant cognitive or communication impairments.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Risk Assessment of Disability and Precision Intervention

    Other intervention

    Implement a digital platform for elderly disability risk intervention to conduct comprehensive, multi-scenario intelligent assessments, dynamic monitoring, and targeted interventions for disability risks.

Treatment groups

238 Participants
are divided into 2 treatment groups
Group A: Experimental groupExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

SPPB(SHORT PHYSICAL PERFORMANCE BATTERY PROTOCOL)

the range of score is 0-12, and the higher scores mean a better outcome.

Time frame
At baseline, 3 months after intervention, and 6 months after intervention

Secondary outcomes

1

Incidence of disability

The incidence of disability will be assessed using validated scales for Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL). Disability is defined as a new-onset, significant limitation in performing basic or complex everyday activities. The occurrence (i.e., the number of new cases) of disability will be determined at predefined study timepoints. The final outcome will be calculated as the proportion or rate of participants who develop disability during the study period, relative to the total number of participants.

Time frame
6 months after intervention
2

Disability Risk Score

The Disability Risk Score is a continuous variable ranging from 0 to 1, calculated using a pre-validated prediction model. A higher score indicates a greater predicted risk of developing disability.

Time frame
At baseline, 3 months after intervention, and 6 months after intervention
3

Intervention adherence

Adherence to the intervention protocol (e.g., exercise, dietary tasks) will be objectively monitored and recorded via a dedicated smartphone application. Participants are required to log or "check-in" within the app upon completion of each prescribed task. Adherence rates will be calculated as the percentage of completed tasks logged, relative to the total number of tasks assigned during the study period.

Time frame
3 months after intervention, and 6 months after intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.